/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Red-flag signs and symptoms of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy in the TTRACK study
Event: Heart Failure 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic heart failure - epidemiology, prognosis, outcome 7
REALM-DCM: a phase 3, multinational, randomized, placebo-controlled study of ARRY-371797 (PF-07265803) in patients with symptomatic LMNA-related dilated cardiomyopathy
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: Chronic heart failure - pharmacotherapy 5
ESC 365 is supported by
